It has previously been suggested that pure allosteric modulators may be advantageous as CCK1R-active drugs to be used in obesity (34) - a positive allosteric modulator of CCK1R possessing no intrinsic agonist activity could enhance the satiety effect of natural CCK when it is released after a meal (34). Here, CCK is linked to obesity due to melanocortin 4 receptor deficiency.